Welcome to DU! The truly grassroots left-of-center political community where regular people, not algorithms, drive the discussions and set the standards. Join the community: Create a free account Support DU (and get rid of ads!): Become a Star Member Latest Breaking News Editorials & Other Articles General Discussion The DU Lounge All Forums Issue Forums Culture Forums Alliance Forums Region Forums Support Forums Help & Search

LiberalArkie

(19,907 posts)
Wed Mar 1, 2023, 07:18 PM Mar 2023

FDA official behind Alzheimer's drug scandal steps down

The Food and Drug Administration official who allegedly had an inappropriately cozy relationship with the maker of the controversial Alzheimer's drug Aduhelm is stepping down from his role, effective immediately, according to numerous media reports.

Billy Dunn, head of the FDA's neuroscience office, has been with the agency for around 18 years, during which he was involved in several high-profile drug approvals. But he gained notoriety in the wake of the shocking 2021 approval of Aduhelm, a drug that has not been shown to be effective against Alzheimer's and carries risks of serious brain swelling.

In 2020, the FDA's independent advisory committee voted nearly unanimously that the agency should not approve the drug (11 of 12 committee members voted against, with one voting "uncertain" ). Yet, the approval went through anyway, and Aduhelm's maker, Biogen, went on to set the exorbitant price of $56,000 for a year's worth of treatment. Outside researchers called the approval "disgraceful," three advisory members resigned in protest, and Medicare Part B premiums rose by record amounts to accommodate covering the pricey drug for Alzheimer's patients desperate for new treatments.

Subsequent media and congressional investigations alleged that Dunn had an off-the-books meeting with Biogen's head scientist two years prior, which kicked off an unusually close collaboration in the lead-up to the approval. For instance, a congressional report released in December 2022 found that some portions of Biogen's documents regarding the drug were written by the FDA and that the agency worked with the company to create briefing documents together. The congressional report concluded that the FDA failed to follow its own rules in its "atypical" interactions with Biogen and that it "inappropriately collaborated" with the company. It also called Aduhelm's price "unjustifiably high."

Snip

https://arstechnica.com/science/2023/02/fda-official-behind-alzheimers-drug-scandal-steps-down/

12 replies = new reply since forum marked as read
Highlight: NoneDon't highlight anything 5 newestHighlight 5 most recent replies
FDA official behind Alzheimer's drug scandal steps down (Original Post) LiberalArkie Mar 2023 OP
He got greedy--and the FDA will pay the price with a loss of its reputation. riversedge Mar 2023 #1
Sadly true. nt crickets Mar 2023 #6
I hope that Biogen and Dunn are tainted into the far distant future. erronis Mar 2023 #8
To the greatest page. Nt BootinUp Mar 2023 #2
The asshole is corrupt to the core - there is a lucrative career ahead dalton99a Mar 2023 #3
As an RN I could have been fired for accepting ten dollars from a patient. markodochartaigh Mar 2023 #4
Medicare recipients paid for it already CountAllVotes Mar 2023 #5
The amount of the Medicare increase was enormous delisen Mar 2023 #7
Hope there is a criminal investigation. The perps (real people) should pay the price. erronis Mar 2023 #9
that's right! CountAllVotes Mar 2023 #11
Here is another article. PurgedVoter Mar 2023 #10
+1 CountAllVotes Mar 2023 #12

erronis

(24,422 posts)
8. I hope that Biogen and Dunn are tainted into the far distant future.
Wed Mar 1, 2023, 10:05 PM
Mar 2023

There need to be radioactive bio-markers placed on people and companies like this that prevent them from ever being trusted in the future.

Unfortunately, this capitalist and corporate-loving country will probably reward both.

markodochartaigh

(5,545 posts)
4. As an RN I could have been fired for accepting ten dollars from a patient.
Wed Mar 1, 2023, 07:32 PM
Mar 2023

At that time all RN's were classified as management and we had to work unpaid overtime, or if we stayed at least a full hour we were paid straight time. And one third of every dollar that the hospital corporation brought in went to administration according to the local newspaper. I know how much Medicare Part B increased for each enrollee, what will Mr Dunn's punishment be?

CountAllVotes

(22,240 posts)
5. Medicare recipients paid for it already
Wed Mar 1, 2023, 07:34 PM
Mar 2023

If you noticed that Medicare Part B went down to $165.00 this year from $170.00 last year, that is because it was jacked up and ready to go to pay for the "new" Alzheimer's drug in 2022.

Once there was no new Alzheimer's drug to be had, they dropped Part B to $165.00 this year!

I think those of us paying for Part B deserve a refund!



delisen

(7,418 posts)
7. The amount of the Medicare increase was enormous
Wed Mar 1, 2023, 08:51 PM
Mar 2023

I wonder if there is a Criminal investigation.

erronis

(24,422 posts)
9. Hope there is a criminal investigation. The perps (real people) should pay the price.
Wed Mar 1, 2023, 10:06 PM
Mar 2023

Not the taxpayers and patients.

PurgedVoter

(2,719 posts)
10. Here is another article.
Wed Mar 1, 2023, 10:28 PM
Mar 2023
https://www.science.org/content/blog-post/underside-aducanumab-approval

I think the company involved should no longer be allowed to work in the industry. Management and owners need to pay the price.
Latest Discussions»General Discussion»FDA official behind Alzhe...